Burning Rock Biotech Stock Probability of Future Stock Price Finishing Under 6.0

BNR Stock  USD 6.58  0.43  6.99%   
Burning Rock's future price is the expected price of Burning Rock instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Burning Rock Biotech performance during a given time horizon utilizing its historical volatility. Check out Burning Rock Backtesting, Burning Rock Valuation, Burning Rock Correlation, Burning Rock Hype Analysis, Burning Rock Volatility, Burning Rock History as well as Burning Rock Performance.
  
As of 12/20/2024, Price To Sales Ratio is likely to drop to 1.19. In addition to that, Price Earnings Ratio is likely to drop to -1.09. Please specify Burning Rock's target price for which you would like Burning Rock odds to be computed.

Burning Rock Target Price Odds to finish below 6.0

The tendency of Burning Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 6.00  or more in 90 days
 6.58 90 days 6.00 
about 88.19
Based on a normal probability distribution, the odds of Burning Rock to drop to $ 6.00  or more in 90 days from now is about 88.19 (This Burning Rock Biotech probability density function shows the probability of Burning Stock to fall within a particular range of prices over 90 days) . Probability of Burning Rock Biotech price to stay between $ 6.00  and its current price of $6.58 at the end of the 90-day period is about 5.99 .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.83 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Burning Rock will likely underperform. Moreover Burning Rock Biotech has an alpha of 1.1478, implying that it can generate a 1.15 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Burning Rock Price Density   
       Price  

Predictive Modules for Burning Rock

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Burning Rock Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.336.6214.90
Details
Intrinsic
Valuation
LowRealHigh
0.244.8113.09
Details
1 Analysts
Consensus
LowTargetHigh
3.603.964.40
Details

Burning Rock Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Burning Rock is not an exception. The market had few large corrections towards the Burning Rock's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Burning Rock Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Burning Rock within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.15
β
Beta against Dow Jones1.83
σ
Overall volatility
1.50
Ir
Information ratio 0.14

Burning Rock Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Burning Rock for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Burning Rock Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Burning Rock Biotech is way too risky over 90 days horizon
Burning Rock Biotech appears to be risky and price may revert if volatility continues
Burning Rock Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 537.43 M. Reported Net Loss for the year was (653.69 M) with profit before taxes, overhead, and interest of 380.04 M.
Burning Rock Biotech has about 1.15 B in cash with (255.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Burning Rock Biotech has a poor financial position based on the latest SEC disclosures
Roughly 61.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Objective longshort Report - Stock Traders Daily

Burning Rock Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Burning Stock often depends not only on the future outlook of the current and potential Burning Rock's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Burning Rock's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding10.2 M
Cash And Short Term Investments615.1 M

Burning Rock Technical Analysis

Burning Rock's future price can be derived by breaking down and analyzing its technical indicators over time. Burning Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Burning Rock Biotech. In general, you should focus on analyzing Burning Stock price patterns and their correlations with different microeconomic environments and drivers.

Burning Rock Predictive Forecast Models

Burning Rock's time-series forecasting models is one of many Burning Rock's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Burning Rock's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Burning Rock Biotech

Checking the ongoing alerts about Burning Rock for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Burning Rock Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Burning Rock Biotech is way too risky over 90 days horizon
Burning Rock Biotech appears to be risky and price may revert if volatility continues
Burning Rock Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 537.43 M. Reported Net Loss for the year was (653.69 M) with profit before taxes, overhead, and interest of 380.04 M.
Burning Rock Biotech has about 1.15 B in cash with (255.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Burning Rock Biotech has a poor financial position based on the latest SEC disclosures
Roughly 61.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Objective longshort Report - Stock Traders Daily

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.